Hemera Biosciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

Hemera Biosciences General Information

Description

Developer of a gene therapy platform designed for the treatment of age-related macular degeneration. The company's platform offers therapy with a patented complement-blocking drug targeting the progression of dry AMD (age-related macular degeneration) with a single interocular injection, thereby enabling patients to the treatment of both dry and wet macular degeneration.

Contact Information

Website
www.hemerabiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 800 South Street
  • Suite 600
  • Waltham, MA 02453
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Digital Health, HealthTech, Life Sciences
Corporate Office
  • 800 South Street
  • Suite 600
  • Waltham, MA 02453
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemera Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jan-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Apr-2013 Completed Generating Revenue
1. University Spin-Out 01-Aug-2010 Completed Startup
To view Hemera Biosciences’s complete valuation and funding history, request access »

Hemera Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Hemera Biosciences’s complete cap table history, request access »

Hemera Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene therapy platform designed for the treatment of age-related macular degeneration. The company's platf
Drug Discovery
Waltham, MA
2 As of 2021

San Juan Capistrano, CA
 

Stuart, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hemera Biosciences Competitors (48)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Allegro Ophthalmics Venture Capital-Backed San Juan Capistrano, CA
Stuart Therapeutics Venture Capital-Backed Stuart, FL
Coave Therapeutics Venture Capital-Backed Paris, France
Ember Therapeutics Formerly VC-backed New York, NY
Lineage Cell Therapeutics Corporation Carlsbad, CA
You’re viewing 5 of 48 competitors. Get the full list »

Hemera Biosciences Executive Team (4)

Name Title Board Seat
Adam Rogers MD Co-Founder and Chief Executive Officer
Elias Reichel MD Co-Founder & Board Member
Jay Duker MD Co-Founder, President & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Hemera Biosciences Board Members (2)

Name Representing Role Since
Elias Reichel MD Hemera Biosciences Co-Founder & Board Member
Jay Duker MD Self Co-Founder, President & Board Member
To view Hemera Biosciences’s complete board members history, request access »

Hemera Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Hemera Biosciences FAQs

  • When was Hemera Biosciences founded?

    Hemera Biosciences was founded in 2010.

  • Who is the founder of Hemera Biosciences?

    Adam Rogers MD, Elias Reichel MD, Rajendra Kumar-Singh Ph.D, and Jay Duker MD are the founders of Hemera Biosciences.

  • Who is the CEO of Hemera Biosciences?

    Adam Rogers MD is the CEO of Hemera Biosciences.

  • Where is Hemera Biosciences headquartered?

    Hemera Biosciences is headquartered in Waltham, MA.

  • What is the size of Hemera Biosciences?

    Hemera Biosciences has 2 total employees.

  • What industry is Hemera Biosciences in?

    Hemera Biosciences’s primary industry is Drug Discovery.

  • Is Hemera Biosciences a private or public company?

    Hemera Biosciences is a Private company.

  • What is Hemera Biosciences’s current revenue?

    The current revenue for Hemera Biosciences is .

  • How much funding has Hemera Biosciences raised over time?

    Hemera Biosciences has raised $3.75M.

  • Who are Hemera Biosciences’s competitors?

    Allegro Ophthalmics, Stuart Therapeutics, Coave Therapeutics, Ember Therapeutics, and Lineage Cell Therapeutics are some of the 48 competitors of Hemera Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »